-
Loading metrics
Open Access
Peer-reviewed
Research Article
C-reactive protein-to-lymphocyte ratio is a novel biomarker for predicting the long-term efficacy of ustekinumab treatment in ulcerative colitis
-
Ryoji Koshiba ,
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Data curation, Writing – original draft
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯ -
Kazuki Kakimoto ,
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Conceptualization, Formal analysis, Writing – original draft
* E-mail: kazuki.kakimoto@ompu.ac.jpt
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯ -
Noboru Mizuta ,
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Data curation, Writing – review & editing
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯ -
Keijiro Numa ,
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Data curation, Writing – review & editing
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯ -
Naohiko Kinoshita ,
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Data curation, Writing – review & editing
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯ -
Kei Nakazawa ,
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Data curation, Writing – review & editing
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯ -
Yuki Hirata ,
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Data curation, Writing – review & editing
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯ -
Takako Miyazaki ,
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Data curation, Writing – review & editing
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯ -
Kazuhide Higuchi ,
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Supervision
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯ -
Shiro Nakamura ,
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Supervision
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯ -
Hiroki Nishikawa
Contributed equally to this work with: Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Yuki Hirata, Takako Miyazaki, Kazuhide Higuchi, Shiro Nakamura, Hiroki Nishikawa
Roles Supervision
Affiliation 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
⨯
C-reactive protein-to-lymphocyte ratio is a novel biomarker for predicting the long-term efficacy of ustekinumab treatment in ulcerative colitis
- Ryoji Koshiba,
- Kazuki Kakimoto,
- Noboru Mizuta,
- Keijiro Numa,
- Naohiko Kinoshita,
- Kei Nakazawa,
- Yuki Hirata,
- Takako Miyazaki,
- Kazuhide Higuchi,
- Shiro Nakamura
- Published: August 29, 2024
- https://doi.org/10.1371/journal.pone.0305324